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HYPOTHESIS: As the Notchhi GSCs present the broadest differentiation potential, we hypothesize that this is the main GBM cell population responsible for tumour relapse. IMP2-
targeting could be used to block oxidative metabolism, and consequently, Notchhi GSCs growth, giving rise to a potential adjuvant therapy with ability to improve the clinical outcome.
To propose an experimental design in order to:
1. Evaluate in vitro the effect of IMP2-shRNA knockdown (KD) on the metabolism and survival of the Notchhi GSCs.
2. Elucidate in vivo the use of IMP2 KD as a therapeutic approach to avoid tumour relapse.
3. Characterize the impact of IMP2 KD on the CD133hi GSCs, NSTCs and neural progenitor cells (NPCs).
PROJECT GOALS
• Bibliographic search in PubMed to identify relevant references.
o Keywords: “Glioblastoma multiforme”, “Glioblastoma Stem Cells”, “metabolism”, “oxidative phosphorylation”, “IMP2”.
o Publication years: 2004-2018.
• Identification of the materials and methods applicable to the proposed experimental design and protocols reading.
METHODOLOGY
EXPERIMENTAL DESIGN
YEAR 1 – Cell culture establishment YEAR 2 – In vitro functional metabolic analysis
YEAR 2 – In vitro study of IGF2/AKT/mTOR pathway activation YEAR 2 – In vitro apoptosis and proliferation analysis
YEAR 3 – In vivo tumour growth and survival analysis
• IMP2 downregulation causes a decrease in cell viability and proliferation of the
Notchhi GSCs in vitro due to impaired oxidative phosphorylation.
• IMP2 downregulation undermines Notchhi GSCs ability to recapitulate a GBM parental
tumour phenotype when used for xenograft establishment in vivo – extending the
survival rate.
• IMP2 downregulation improves the treatment outcome of TMZ chemotherapy.
EXPECTED RESULTS
• This research project will advance the knowledge of the pathophysiological mechanisms of
GBM – and, particularly, the GSCs – to develop new therapy strategies focused on GSCs
metabolism to avoid tumour relapse.
• The obtained results could give rise to the development of IMP2-targeting drugs to be used
in combination therapies both with TMZ chemotherapy and drugs targeting other GBM cell
populations.
CONCLUSION
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Glioblastoma multiforme (GBM) is the most prevalent and lethal brain tumour, characterized by a low survival rate and a lack of effective treatment options. As its high intra-tumoural heterogeneity and the presence of glioblastoma
stem cells (GSCs) are the cornerstones of therapeutic resistance, novel therapeutic approaches should target the GSC population as a means to avoid tumour relapse, being a potential strategy to attack GSCs metabolism.
GBM contains different GSCs populations:
• Notchhi GSCs rely on oxidative metabolism and show the broadest differentiation potential. 
• CD133hi GSCs recur to anaerobic glycolysis and present a reduced differentiation potential. 
IMP2 is an oncofetal mRNA binding protein expressed in GSCs and essential for 
their function through several pathways, particularly, oxidative phosphorylation.  
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PROJECT BACKGROUND
GBM cellular structure IMP2 function
The results will be communicated to the academic and
private sector through:
• Publication in high impact journals.
• National and international conferences.
• Seminars.
DISSEMINATION PLAN
OCR – Oxygen Consumption Rate 
ECAR – Extracellular Acidification Rate
Western Blot
• mTORC1 activation status:
o P-S6K/S6K
o P-4EBP/4EBP
o P-IMP2/IMP2
• Upstream pathway activation:
o P-INSR/INSR
o P-IGF1R/IGF1R
o P-AKT/AKT
o IGF2
RT-qPCR
• Downstream metabolic changes:
o Key glycolysis, PPP and lipid 
biosynthesis enzymes 
expression. 
